BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
18.92
-0.45 (-2.32%)
Dec 29, 2025, 3:38 PM EST - Market open
BrainsWay Employees
BrainsWay had 120 employees as of December 31, 2024. The number of employees decreased by 14 or -10.45% compared to the previous year.
Employees
120
Change (1Y)
-14
Growth (1Y)
-10.45%
Revenue / Employee
$409,117
Profits / Employee
$52,067
Market Cap
384.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120 | -14 | -10.45% |
| Dec 31, 2023 | 134 | 0 | - |
| Dec 31, 2022 | 134 | 16 | 13.56% |
| Dec 31, 2021 | 118 | 18 | 18.00% |
| Dec 31, 2020 | 100 | -7 | -6.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BWAY News
- 7 days ago - BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™ - GlobeNewsWire
- 4 weeks ago - BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript - Seeking Alpha
- 4 weeks ago - BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025 - GlobeNewsWire
- 6 weeks ago - BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder - GlobeNewsWire
- 6 weeks ago - BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 - GlobeNewsWire
- 6 weeks ago - BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 7 weeks ago - BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder - GlobeNewsWire